StockData
Soligenix, Inc. logo

Soligenix, Inc. (SNGX) stock

SNGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$0.25−0.03 (-9.88%)

Close on Nov 18, 2026Market cap $5.50MP/E –Yield –

Soligenix operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Soligenix's operating cash flow for the twelve months ending Jun 30, 2026 was -$9.74M. For fiscal 2025 it was -$10.27M. The highest annual figure on record is $2.64M in fiscal 2012.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$10.27M–
FY2024Dec 31, 2024-$8.40M–
FY2023Dec 31, 2023-$8.60M–
FY2022Dec 31, 2022-$12.65M–
FY2021Dec 31, 2021-$11.74M–
FY2020Dec 31, 2020-$11.45M–
FY2019Dec 31, 2019-$7.51M–
FY2018Dec 31, 2018-$7.24M–
FY2017Dec 31, 2017-$6.51M–
FY2016Dec 31, 2016-$4.98M–
FY2015Dec 31, 2015-$5.39M–
FY2014Dec 31, 2014-$2.47M–
FY2013Dec 31, 2013-$4.46M-269.1%
FY2012Dec 31, 2012$2.64M–
FY2011Dec 31, 2011-$1.95M–
FY2010Dec 31, 2010-$5.73M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.71M–
Q1 FY2026Mar 31, 2026-$2.36M–
Q4 FY2025Dec 31, 2025-$2.75M–
Q3 FY2025Sep 30, 2025-$2.93M–
Q2 FY2025Jun 30, 2025-$2.74M–
Q1 FY2025Mar 31, 2025-$1.85M–
Q4 FY2024Dec 31, 2024-$2.23M–
Q3 FY2024Sep 30, 2024-$2.91M–
Q2 FY2024Jun 30, 2024-$1.92M–
Q1 FY2024Mar 31, 2024-$1.34M–
Q4 FY2023Dec 31, 2023-$1.83M–
Q3 FY2023Sep 30, 2023-$2.69M–
Q2 FY2023Jun 30, 2023-$1.92M–
Q1 FY2023Mar 31, 2023-$2.17M–
Q4 FY2022Dec 31, 2022-$3.63M–
Q3 FY2022Sep 30, 2022-$3.25M–
Q2 FY2022Jun 30, 2022-$2.53M–
Q1 FY2022Mar 31, 2022-$3.24M–
Q4 FY2021Dec 31, 2021-$3.06M–
Q3 FY2021Sep 30, 2021-$3.04M–
Q2 FY2021Jun 30, 2021-$1.66M–
Q1 FY2021Mar 31, 2021-$3.99M–
Q4 FY2020Dec 31, 2020-$4.12M–
Q3 FY2020Sep 30, 2020-$2.99M–
Q2 FY2020Jun 30, 2020-$1.64M–
Q1 FY2020Mar 31, 2020-$2.70M–
Q1 FY2019Mar 31, 2019-$2.29M–
Q4 FY2018Dec 31, 2018-$2.68M–
Q3 FY2018Sep 30, 2018-$967.84K–
Q2 FY2018Jun 30, 2018-$2.14M–
Q1 FY2018Mar 31, 2018-$1.46M–
Q4 FY2017Dec 31, 2017-$2.32M–
Q3 FY2017Sep 30, 2017-$1.21M–
Q2 FY2017Jun 30, 2017-$1.35M–
Q1 FY2017Mar 31, 2017-$1.63M–
Q4 FY2016Dec 31, 2016-$1.43M–
Q3 FY2016Sep 30, 2016-$1.20M–
Q2 FY2016Jun 30, 2016-$1.71M–
Q1 FY2016Mar 31, 2016-$637.84K–

More Soligenix figures

See a number that looks wrong?